BSD Medical Corporation (NASDAQ: BSDM) (the "Company" or "BSD") announced today that a major East Coast academic medical center (the "Center") has purchased a BSD-500 Hyperthermia System (BSD-500). The Center is launching an extensive new hyperthermia program to capitalize on the advantages provided by hyperthermia treatment.
"This latest sale is an indicator of the most recent success of hyperthermia in key academic medical centers for the treatment of certain recurrent cancer patients," said Harold Wolcott, BSD's President.